Johanna I. Kiiski - Concepedia

Author

Johanna I. Kiiski

Also Known As

Elza Khusnutdinova, J I Kiiski, JI. Kiiski, Johanna I Kiiski, Johanna I. Kiiski, Johanna Kiiski, Johanna I. Kiiski, Karin Kast, Lorelei Mucci, Pooja Middha Kapoor

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Helsinki University Hospital University of Turku Fimlab (Finland)

About

Johanna I. Kiiski is an author at University of Helsinki specializing in molecular diagnostics, medicine, and cancer genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	697
2	Pathology	2	2	697
3	Public Health	1	1	669
4	Genetic Medicine	1	1	669
5	Cancer Epidemiology	1	1	669

Johanna I. Kiiski

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, The American Journal of Human Genetics	2018	1.1K
RAD51B in Familial Breast Cancer Liisa M. Pelttari, Sofia Khan, Mikko Vuorela, PLoS ONE Breast OncologyGeneticsGenetic EpidemiologyHuman PolymorphismPathology	2016	669
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer Johanna I. Kiiski, Liisa M. Pelttari, Sofia Khan, Proceedings of the National Academy of Sciences	2014	179
Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness Vivek Patel, Evan L. Busch, Tara M. Friebel, Cancer Research	2019	50
A Finnish founder mutation in <i>RAD51D</i>: analysis in breast, ovarian, prostate, and colorectal cancer: Table 1 Liisa M. Pelttari, Johanna I. Kiiski, Riikka Nurminen, Journal of Medical Genetics	2012	49
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer Gisella Figlioli, Massimo Bogliolo, Irene Catucci, npj Breast Cancer	2019	43
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population Johanna I. Kiiski, Anna Tervasmäki, Liisa M. Pelttari, Breast Cancer Research and Treatment	2017	36
RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families Liisa M. Pelttari, Johanna I. Kiiski, Salla Ranta, SpringerPlus Genome InstabilityBreast OncologyOncologySomatic VariantXrcc2 Mutation Screening	2015	28
Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients Anna Nurmi, Taru Muranen, Liisa M. Pelttari, International Journal of Cancer	2019	28
<i>FANCM</i> c.5101C>T mutation associates with breast cancer survival and treatment outcome Johanna I. Kiiski, Rainer Fagerholm, Anna Tervasmäki, International Journal of Cancer	2016	16

Page 1